Tilray Brands Inc (TLRY)
1.86
-0.50
(-21.19%)
USD |
NASDAQ |
May 26, 16:00
1.89
+0.03
(+1.61%)
Pre-Market: 20:00
Tilray Brands Enterprise Value: 1.337B for May 26, 2023
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 26, 2023 | 1.337B |
May 25, 2023 | 1.646B |
May 24, 2023 | 1.683B |
May 23, 2023 | 1.702B |
May 22, 2023 | 1.751B |
May 19, 2023 | 1.677B |
May 18, 2023 | 1.695B |
May 17, 2023 | 1.677B |
May 16, 2023 | 1.640B |
May 15, 2023 | 1.689B |
May 12, 2023 | 1.677B |
May 11, 2023 | 1.689B |
May 10, 2023 | 1.887B |
May 09, 2023 | 1.868B |
May 08, 2023 | 1.905B |
May 05, 2023 | 1.899B |
May 04, 2023 | 1.745B |
May 03, 2023 | 1.664B |
May 02, 2023 | 1.596B |
May 01, 2023 | 1.596B |
April 28, 2023 | 1.640B |
April 27, 2023 | 1.664B |
April 26, 2023 | 1.535B |
April 25, 2023 | 1.572B |
April 24, 2023 | 1.640B |
Date | Value |
---|---|
April 21, 2023 | 1.609B |
April 20, 2023 | 1.640B |
April 19, 2023 | 1.677B |
April 18, 2023 | 1.714B |
April 17, 2023 | 1.732B |
April 14, 2023 | 1.652B |
April 13, 2023 | 1.702B |
April 12, 2023 | 1.705B |
April 11, 2023 | 1.745B |
April 10, 2023 | 1.881B |
April 06, 2023 | 1.794B |
April 05, 2023 | 1.695B |
April 04, 2023 | 1.726B |
April 03, 2023 | 1.757B |
March 31, 2023 | 1.751B |
March 30, 2023 | 1.744B |
March 29, 2023 | 1.782B |
March 28, 2023 | 1.732B |
March 27, 2023 | 1.800B |
March 24, 2023 | 1.806B |
March 23, 2023 | 1.800B |
March 22, 2023 | 1.775B |
March 21, 2023 | 1.831B |
March 20, 2023 | 1.720B |
March 17, 2023 | 1.800B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
562.09M
Minimum
Mar 18 2020
9.965B
Maximum
Jun 09 2021
2.769B
Average
2.000B
Median
Feb 14 2023
Enterprise Value Benchmarks
SNDL Inc | 235.33M |
Neptune Wellness Solutions Inc | 17.04M |
Clever Leaves Holdings Inc | 6.704M |
Acasti Pharma Inc | -6.951M |
Aurinia Pharmaceuticals Inc | 995.86M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -1.171B |
Revenue (Quarterly) | 145.59M |
Total Expenses (Quarterly) | 233.80M |
EPS Diluted (Quarterly) | -1.90 |
Gross Profit Margin (Quarterly) | -8.04% |
Profit Margin (Quarterly) | -804.3% |
Earnings Yield | -163.4% |
Normalized Earnings Yield | -44.98 |